Testing a new medicine’s safety in healthy adults
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This Phase 1 study tests how a new medicine (TBN) behaves in the body after several doses, including side effects and tolerability. It is meant for healthy adults to help researchers decide how it can be used safely in future studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be male or a non-pregnant, non-childbearing potential female, age 18–50
- Be a non-smoker (no tobacco or nicotine products in the last 3 months)
- Have a BMI between 18 and 30, and weigh at least 50 kg (men) or 45 kg (women)
- Be generally healthy with no major medical problems or surgeries in the last 4 weeks
- Pass infection and screening tests (no hepatitis B/C, HIV, or serious abnormal labs)
- Be able to use reliable birth control rules (if you could become pregnant) and give consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine (BI 3776528) in healthy men to see how well different doses are tolerated. It helps researchers find the safest dose before testing in people with a condition.
This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.
This trial tests a new drug called CAY001 in healthy volunteers to see how safe it is and how the body processes it. It may help researchers understand if the drug is safe enough to test in people with medical conditions later.
This trial tests how safe and tolerable different doses of the study drug BI 3814916 are in healthy adults. It helps find the right dose for future studies.
This study tests a new medicine, called BLKR201, for the first time in people. It is given to healthy volunteers to see how safe it is and how the body handles it.
This phase 1 study tests an experimental drug called TIX100 in healthy volunteers to check its safety and how the body processes it. The results will help determine if the drug can be studied in future trials for conditions like obesity or metabolic disorders.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.